Medication adherence study tops glaucoma coverage
Click Here to Manage Email Alerts
Studies on medication adherence and long-term iStent outcomes led Healio/OSN’s glaucoma coverage in May. These are the top five recent glaucoma articles:
Medication adherence, visual field loss significantly associated
In patients with glaucoma who reported never missing a single dose of medication over 8 years, the estimated loss of visual field was significantly less when compared with patients who reported missing doses, according to a study. Read more.
Visual field, OCT outcomes stabilize after iStent implantation
Both IOP and medication use were reduced and glaucoma did not progress in the majority of patients in a study looking at 5-year visual field and OCT outcomes after iStent implantation in a real-world clinical setting. Read more.
Researchers attempt to define criteria for glaucomatous optic neuropathy
Defining objective criteria for glaucomatous optic neuropathy, rather than relying on clinical assessments alone, is needed for comparing outcomes across clinical research studies, according to a speaker at the virtual Association for Research in Vision and Ophthalmology meeting. Read more.
Xen gel stent with phaco has similar endothelial cell density loss as cataract surgery alone
Patients who underwent Xen gel stent implantation combined with phacoemulsification to treat primary or secondary open-angle glaucoma experienced a similar central endothelial cell density loss at 2 years as those who underwent stand-alone phacoemulsification, according to a study. Read more.
Santen introduces earth-friendly eye drop bottles
An eye drop used to treat glaucoma will now be offered in an environmentally friendly bottle, Santen announced in a press release. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts